Professor
Dr. Mardis is the co-holder of five U.S. patents, including her most recent one for patient-specific, mutation-directed immunotherapy for cancer. She has co-authored more than 350 articles in well-respected publications, including Cell, Journal of Clinical Oncology, Blood and Cancer Epidemiology, Biomarkers and Prevention. She was recently elected to the National Academy of Science and is the President of the American Association for Cancer Research.
Research Interests
- Cancer Genomics
Education
PhD: University of Oklahoma